Invention Grant
- Patent Title: Anti-IL-4R antibody and use thereof
-
Application No.: US17049288Application Date: 2018-08-13
-
Publication No.: US11897960B2Publication Date: 2024-02-13
- Inventor: Zhigang Liu , Yulan Liu , Xiaobo Hao , Lei Jiang , Jingjing Guo
- Applicant: Beijing Wisdomab Biotechnology Co., Ltd , Genrix (Shanghai) Biopharmaceutical Co. Ltd. , Chongqing Genrix Biopharmaceutical Co., Ltd.
- Applicant Address: CN Beijing
- Assignee: Beijing Wisdomab Biotechnology Co., Ltd,Genrix (Shanghai) Biopharmaceutical Co. Ltd.,Chongqing Genrix Biopharmaceutical Co., Ltd.
- Current Assignee: Beijing Wisdomab Biotechnology Co., Ltd,Genrix (Shanghai) Biopharmaceutical Co. Ltd.,Chongqing Genrix Biopharmaceutical Co., Ltd.
- Current Assignee Address: CN Beijing; CN Shanghai; CN Chongqing
- Agency: Cozen O'Connor
- Priority: CN 1810360234.5 2018.04.20
- International Application: PCT/CN2018/100263 2018.08.13
- International Announcement: WO2019/200787A 2019.10.24
- Date entered country: 2020-10-20
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/00
Abstract:
Disclosed in the present application are an antibody or an antigen-binding portion thereof binding to human IL-4R, a polynucleotide encoding the antibody or antigen-binding portion thereof, a vector comprising the polynucleotide, a host cell comprising the polynucleotide or vector, a method for preparing and purifying the antibody, and the use of the antibody or antigen-binding portion thereof.
Public/Granted literature
- US20220081485A1 ANTI-IL-4R ANTIBODY AND USE THEREOF Public/Granted day:2022-03-17
Information query
